TITLE

Sharp fall in rates of second treatment failure and death after second failure

PUB. DATE
April 2010
SOURCE
HIV Treatment ALERTS!;Apr2010, p32
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses the study conducted in 1996 through 2005 regarding the rates of second treatment failure in people with HIV in the U.S. and Canada. It says that the study covers the assessment of HIV-infected people ages 18 above who underwent antiretroviral therapy wherein their first antiretroviral combination failed. The researchers of the study view the results of the study as an indication of the improvement of the effectiveness of combination therapy.
ACCESSION #
50843460

 

Related Articles

  • Early Virologic Failure in a Pilot Study Evaluating the Efficacy of Therapy Containing Once-Daily Abacavir, Lamivudine, and Tenofovir DF in Treatment-Naive HIV-Infected Patients. Khanlou, Homayoun; Yeh, Vivian; Guyer, Bill; Farthing, Charles // AIDS Patient Care & STDs;Mar2005, Vol. 19 Issue 3, p135 

    Previous investigational data using abacavir (ABC), lamuvidine (3TC), and zidovudine has suggested the possibility of triple nucleoside analogue reverse transcriptase inhibitors (NRTI) therapy as an option in the treatment of HIV infection. We performed a pilot study to assess the potency of...

  • Three-Class Antiretroviral Resistance in a Patient with Acute HIV-1 Infection. Gentz, Mark; Levin, Todd P.; Klibanov, Olga M.; Feingold, Anat; Condoluci, David V. // AIDS Patient Care & STDs;Nov2006, Vol. 20 Issue 11, p741 

    Antiretroviral resistance in treatment-naïve patients with HIV-1 infection is on the rise in both resource-rich and resource-poor countries. We report a case of three-class primary antiretroviral resistance detected by a genotypic assay in a 19-year-old woman with acute HIV-1 infection. Her...

  • HIV-associated early gastric adenocarcinoma successfully cured with surgery, and followed over eight years. Manfredi, Roberto; Sabbatani, Sergio; Fasulo, Giovanni // International Journal of STD & AIDS;Jul2007, Vol. 18 Issue 7, p501 

    An extremely rare case report of HIV-associated gastric adenocarcinoma surgically treated in the year 1998 in a 37-year-old male patient already HIV positive for 10 years, with a complete post-surgery disease-free follow-up of eight years, is described. An international literature search allowed...

  • South Africans Win Some, Lose Some. Houlton, Sarah // Pharmaceutical Executive;Oct2003, Vol. 23 Issue 10, p24 

    Reports that the South African government has approved the provision of antiretroviral drugs to HIV-positive South Africans. Funding by the Global Fund to Fight AIDS, Malaria and Tuberculosis of an AIDS program in KwaZulu Natal.

  • Viral and Latent Reservoir Persistence in HIV-1--Infected Patients on Therapy. Hwijin Kim; Perelson, Alan S. // PLoS Computational Biology;Oct2006, Vol. 2 Issue 10, p1232 

    Despite many years of potent antiretroviral therapy, latently infected cells and low levels of plasma virus have been found to persist in HIV-infected patients. The factors influencing this persistence and their relative contributions have not been fully elucidated and remain controversial....

  • Decreasing HIV Drug Resistance in the United Kingdom.  // Clinical Infectious Diseases;9/1/2007, Vol. 45 Issue 5, pvi 

    The article discusses the study "A decreasing prevalence of antiretroviral drug resistance in the UK: evidence of a decline in transmitted HIV-1 drug resistance in the United Kingdom." In the study, the researchers conducted analysis of major resistance mutations to determine time-dependent...

  • Etravirine. Haubrich, Richard; Gubernick, Steven; Yasothan, Uma; Kirkpatrick, Peter // Nature Reviews Drug Discovery;Apr2008, Vol. 7 Issue 4, p287 

    Etravirine (Intelence; Tibotec) is a non-nucleoside inhibitor of HIV-1 reverse transcriptase. In January 2008, it was approved by the US FDA for the treatment of HIV-1 infection in combination with other antiretroviral agents for treatment-experienced patients who have HIV-1 strains that are...

  • Early Treatment and HIV-1 Reservoirs: A Stitch in Time? Henrich, Timothy J.; Gandhi, Rajesh T. // Journal of Infectious Diseases;Oct2013, Vol. 208 Issue 8, p1189 

    The article presents the author's comments on the implications of antiretroviral therapy (ART) during acute human immunodeficiency virus type 1 (HIV-1) infection on viral reservoirs. It specifically refers to a study which examined HIV-1 nucleic acid levels and T-cell activation in patients who...

  • Immune recovery among HIV-infected patients in northwestern Tanzania after 2 years of anti-retroviral therapy use: a retrospective cohort study. MPONDO, BONAVENTURA C. T.; KABANGILA, RODRICK; EPHRAIM, LUCHERI; ERNEST, ALEX; KIDENYA, BENSON R. // Tanzania Journal of Health Research;Oct2015, Vol. 17 Issue 4, p1 

    Background: The use of antiretroviral therapy (ART) for the treatment of human immunodeficiency virus (HIV) is associated with significant and sustained decrease in the viral RNA levels that allows the immune system to recover. The extent of this immune recovery depends on the baseline CD4...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics